OpenAI - OpenAI DevDay 2024 | Community Spotlight | Genmab
Genmab, a biotech company, is leveraging AI to streamline the clinical trial process, which is traditionally lengthy and costly. The company has developed a framework called CELI to automate the generation of regulatory documents required for clinical trials. These documents, which detail patient information and trial data, are typically labor-intensive and require high accuracy. CELI uses a language model to process natural language inputs, plan tasks, and self-correct, ensuring 100% accuracy in document generation. This system significantly reduces the time needed to compile documents, transforming a process that could take hours into one that takes minutes. By accelerating documentation, Genmab aims to shorten clinical trials, allowing faster access to treatments for patients with serious diseases.
Key Points:
- Genmab uses AI to speed up clinical trial documentation, reducing time from hours to minutes.
- CELI framework ensures 100% accuracy in generating regulatory documents.
- AI processes natural language, plans tasks, and self-corrects to maintain accuracy.
- Shortening trial times can provide faster access to treatments for serious diseases.
- CELI is open source, inviting collaboration for further development.
Details:
1. 🎉 Introduction and Excitement
- AI agents were used to significantly accelerate the clinical trial process, reducing time and increasing efficiency.
- Scott leads the AI innovation team at Genmab, focusing on AI-driven advancements in clinical trials.
- The strategic implementation of AI agents has enhanced the efficiency of clinical trials, potentially reducing the development cycle and improving outcomes.
2. 🔬 Genmab's Commitment to Innovation
- Genmab is a biotech company focused on biology and antibodies, emphasizing innovation.
- The company is committed to advancing AI, not just adopting it, to enhance its operations.
- Genmab aims to improve the clinical trial process, which currently takes over eight years and costs billions for a single medicine in one disease.
- AI is seen as a key tool to reduce the time and cost of clinical trials, making them more scalable.
- Genmab is exploring AI applications to streamline drug discovery and development processes, potentially reducing the time to market for new therapies.
- The company is investing in AI-driven platforms to analyze biological data more efficiently, aiming to accelerate research and development cycles.
3. 📄 AI in Clinical Trials: Document Generation
3.1. Challenges in Document Generation for Clinical Trials
3.2. Solutions: The CELI Framework
4. 🛠️ CELI Framework: Achieving Accuracy
4.1. Planning and Execution
4.2. Self-Correction and Evaluation
4.3. Achieving 100% Accuracy
5. 🚀 CELI in Action: Demonstration
- CELI progressively learns about the patient, drafting documents step by step and section by section, using a retrieval process to gather necessary information efficiently.
- The system begins with a series of prompts that specify the job, including a defined role and objective for drafting a document, and a checklist of tasks to be completed in a specific order.
- If a task cannot be completed, CELI is designed to address the issue, guided by instructions from medical writers and clinicians, ensuring adaptability and problem-solving.
- Prompt completion mechanics are crucial, ensuring CELI communicates completed tasks, current work, and upcoming tasks clearly and effectively.
- CELI uses function calls to retrieve and maintain context for IDs or keys, allowing precise key-value pair lookups during function calls, enhancing accuracy.
- The system message sent to GPT includes a blueprint, ensuring consistent guidance and adherence to the document structure throughout the process.
- CELI drafts sections of a document once all necessary tables are retrieved, compiling them accurately into a complete draft, demonstrating efficiency and precision.
- A monitoring agent confirms the completion and saving of the draft, ensuring all tasks are completed in sequence, maintaining workflow integrity.
6. 🌟 Impact and Invitation
- Sam's process reduces task time from hours to minutes, impacting thousands of patients across various trials.
- Shaving a month off a trial can provide access to drugs for hundreds or thousands of people with serious diseases.
- The motivation for the work is solving significant health problems, inviting others to join through open-source collaboration.